Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Vertical transmission of tumour resistance in guinea pigs

Abstract

BOTH intact bacillus Calmette–Guerin(BCG)1–3 and the methanol extraction residue (MER) fraction4 of BCG have had extensive application in tumour immunotherapy. Treatment with MER nonspecifically stimulates both the cellular and humoral immune systems4,5, and has been successful in tumour immunotherapy in a number of animal models6,7. Experiments in our laboratories, using animals obtained from the Weizmann Institute, Rehovot, Israel, have shown that about 40% of strain 2 guinea pigs injected with MER or with the supernatant of sonically-disrupted BCG (BCG SS), 1–2 months before intradermal inoculation with 106 cells of the transplantable line 10 hepatocarcinoma8,9, are resistant to the growth of this tumour10. Similarly, injection of MER into developing tumour nodules 7d after tumour cell implantation results in complete tumour regression in approximately 40% of the animals tested (M.A.W., P.M. and D.W.W., unpublished).

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Old, L. J., Clarke, D. A., and Benacerraf, B., Nature, 184, 291–292 (1959).

    Article  ADS  Google Scholar 

  2. Mathe, G., Kamel, M., Dezfulian, M., Halle-Pannenko, O., and Bourut, C., Cancer Res., 33, 1987–1997 (1973).

    CAS  PubMed  Google Scholar 

  3. Pimm, M. V., and Baldwin, R. W., Int. J. Cancer, 15, 260–269 (1975).

    Article  CAS  Google Scholar 

  4. Weiss, D. W., Natn. Cancer Inst. Monogr., 35, 157–171 (1972).

    CAS  Google Scholar 

  5. Ben-Efraim, S., Constantini-Sourojon, M., and Weiss, D. W., Cell Immun., 7, 370–379 (1973).

    Article  CAS  Google Scholar 

  6. Haran-Ghera, N., and Weiss, D. W., J. natn. Cancer Inst., 50, 229–234 (1973).

    Article  CAS  Google Scholar 

  7. Hopper, D. G., Pimm, M. V., and Baldwin, R. W., Br. J. Cancer, 31, 176–181 (1975).

    Article  CAS  Google Scholar 

  8. Zbar, B., Bernstein, I., Tanaka, T., and Rapp, H. J., Science, 170, 1217–1218 (1970).

    Article  ADS  CAS  Google Scholar 

  9. Zbar, B., and Tanaka, T., Science, 172, 271–273 (1971).

    Article  ADS  CAS  Google Scholar 

  10. Minden, P., Wainberg, M., and Weiss, D. W., J. natn. Cancer Inst., 52, 1643–1645 (1974).

    Article  CAS  Google Scholar 

  11. Barnes, J. M., J. Path. Bact., 77, 371–380 (1959).

    Article  CAS  Google Scholar 

  12. Minden, P., Sandridge, J., Wainberg, M. A., and McClatchy, J. K., J. natn. Cancer Inst. (in the press).

  13. Meltzer, M. S., Leonard, E. J., Rapp, H. J., and Borsos, T., J. natn. Cancer Inst., 47, 703–709 (1971).

    CAS  Google Scholar 

  14. Brambell, F. W. R., in Transmission of Passive Immunity from Mother to Young, 142–165 (North-Holland, Amsterdam, 1970).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

WAINBERG, M., MINDEN, P. & WEISS, D. Vertical transmission of tumour resistance in guinea pigs. Nature 259, 213–215 (1976). https://doi.org/10.1038/259213a0

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/259213a0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing